Radical Surgery in the Presence of Biliary Metallic Stents: Revising the Palliative Scenario

Journal of Gastrointestinal Surgery

Volumn 15, Issue 3, 2011, Pages 489-495

  Lytras, Dimitrios ^a   Olde Damink, Steven W M ^a   Amin, Zahir ^a   Imber, Charles J ^a   Malagó, Massimo ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bile duct; Cholangiocarcinoma; Hepatic confluence; Hilar tumours; Self expanding metallic stents

Indexed keywords

AGED; ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT; BILE DUCT CARCINOMA; CHOLESTASIS; HEPATIC DUCT; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; PATHOLOGY; STENT; TREATMENT OUTCOME;

AGED; AUTOIMMUNE DISEASES; BILE DUCTS; BILE DUCTS, EXTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLESTASIS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; STENTS; TREATMENT OUTCOME;

EID: 79952067889     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1389-2     Document Type: Article

References (21)

1. Costamagna G, Pandolfi M. Endoscopic stenting for biliary and pancreatic malignancies. J Clin Gastroenterol 2004; 38: 59-67.
2. Perdue DG, Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Overby CS, Ryan ME, Bochna GS, Snady HW, Moore JP. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol 2008; 42: 1040-1046.
3. Siriwardana HP, Siriwardena AK. Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture. Ann Surg 2005; 242: 10-19.
4. Huibregtse K, Carr-Locke DL, Cremer M, Domschke W, Fockens P, Foerster E, Hagenmuller F, Hatfield AR, Lefebvre JF, Liquory CL, et al. Biliary stent occlusion--a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy 1992; 24: 391-394.
5. Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosma A, Gouma DJ. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 2001; 88: 48-51.
6. Strasberg SM. Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 1997; 184: 413-434.
7. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
8. Vibert E, Farges O, Regimbeau JM, Belghiti J. Benign hilar biliary strictures stented with metallic stents can be resected by using an oncologic approach. Surgery 2005; 137: 506-510.
9. Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tytgat GN, Huibregtse K. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002; 56: 33-39.
10. Ayaru L, Kurzawinski TR, Shankar A, Webster GJ, Hatfield AR, Pereira SP. Complications and diagnostic difficulties arising from biliary self-expanding metal stent insertion before definitive histological diagnosis. J Gastroenterol Hepatol 2008; 23: 315-320.
11. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 2005; 9: 1094-1104; discussion 1104-1105.
12. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73-83.
13. Belghiti J, Ogata S. Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB (Oxford) 2005; 7: 252-253.
14. Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 2007; 141: 581-588.
15. Dimick JB, Cowan JA, Jr., Knol JA, Upchurch GR, Jr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003; 138: 185-191.
16. Nathan H, Cameron JL, Choti MA, Schulick RD, Pawlik TM. The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship. J Am Coll Surg 2009; 208: 528-538.
17. Joseph B, Morton JM, Hernandez-Boussard T, Rubinfeld I, Faraj C, Velanovich V. Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection. J Am Coll Surg 2009; 208: 520-527.
18. Nguyen GC, Thuluvath NP, Segev DL, Thuluvath PJ. Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transpl 2009; 15: 776-781.
19. Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK, Sung KB, Ko GY: Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Surg 2010; 17: 476-489.
20. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 2006; 244: 230-239.
21. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-1281.